SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-006489
Filing Date
2023-01-11
Accepted
2023-01-11 16:18:58
Documents
17
Period of Report
2023-01-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d405652d8k.htm   iXBRL 8-K 28648
2 EX-99.1 d405652dex991.htm EX-99.1 5679
6 GRAPHIC g405652ex99_1p1g1.jpg GRAPHIC 248364
7 GRAPHIC g405652ex99_1p2g1.jpg GRAPHIC 522990
8 GRAPHIC g405652ex99_1p3g1.jpg GRAPHIC 291040
9 GRAPHIC g405652ex99_1p4g1.jpg GRAPHIC 333160
  Complete submission text file 0001193125-23-006489.txt   2079131

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bmrn-20230109.xsd EX-101.SCH 2842
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmrn-20230109_lab.xml EX-101.LAB 17236
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmrn-20230109_pre.xml EX-101.PRE 10807
11 EXTRACTED XBRL INSTANCE DOCUMENT d405652d8k_htm.xml XML 3272
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26727 | Film No.: 23523801
SIC: 2834 Pharmaceutical Preparations